Biocon Ltd News

Stocks to Watch today, Jan 16: RIL, Infosys, ICICI Pru AMC, Jio Financial

Stocks to watch on January 16, 2026: Stocks like Infosys, ICICI Prudential AMC, Biocon, Angel One and HDB Financial Services will remain in focus today

Biocon raises ₹4,150 crore via QIP issue on strong investor demand

Biotech firm Biocon on Thursday said it has raised Rs 4,150 crore through a Qualified Institutions Placement (QIP) process. The initiative saw issuance of 1,12,664,585 equity shares of face value Rs 5 each to eligible qualified institutional buyers at the issue price of Rs 368.35 per share, the Bengaluru-based firm said in a regulatory filing. The QIP, which opened on January 12 and closed on January 14, attracted strong investor interest from a broad mix of domestic and international participants, reflecting robust confidence in the company's growth prospects, it added. The proceeds from the QIP will be primarily utilised to meet the cash consideration payable to Mylan Inc. (Viatris) for buying out its shareholding in Biocon Biologics Ltd, including repayment of debt availed in this regard, Biocon said. The company recently announced its board has approved a strategic corporate action to acquire all remaining minority shareholdings, including Viatris' stake, thereby making Biocon

Stocks to Watch today, Jan 13: TCS, HCL Tech, Anand Rathi Wealth, Biocon

Stocks to watch on January 13, 2026: Stocks like TCS, HCL Technologies, Anand Rathi Wealth, Biocon and NBCC will remain in focus today

Biocon opens ₹4,500 crore QIP, sets floor price at ₹387.74 per share

Biocon has opened a ₹4,500-crore QIP and fixed a floor price of ₹387.74 per share. The company said it may offer a discount of up to 5% and will finalise pricing with lead managers

Stocks to Watch today, Jan 7: Titan, Biocon, Godrej Con, Lodha, YES Bank

Stocks to Watch today, January 7, 2026: Godrej Consumer, Titan, Jubilant FoodWorks, YES Bank are among key stocks that will be in focus today

New Year picks 2026: Motilal Oswal Wealth bets on Airtel, SBI, Eternal

New Year picks 2026: Motilal Oswal Wealth Management has picked SBI, Airtel, Biocon, Eternal and others for the upcoming year; check details here

Ajanta Pharma signs pact with Biocon to sell semaglutide in 26 countries

Ajanta Pharma has signed an in-licensing pact with Biocon to market semaglutide across 26 countries in Africa, the Middle East and Central Asia, subject to approvals

Stocks to Watch today, Dec 16: Biocon, EIH, Zee Media, HCLTech, MTNL, SBI

Stocks to Watch today, December 16, 2025: HCLTech, MTNL, SBI, EIH and others will remain on investors' radar today

Biocon launches drugs for diabetes and obesity treatment in Netherlands

The Netherlands launch builds on Biocon's entry into the UK in February, where it received regulatory approval for liraglutide from the Medicines and Healthcare Products Regulatory Agency

Biocon-BBL merger positioned to add value, says Nuvama; retains 'Buy' call

The optimism stems from the company's plan to increase its stake in Biocon Biologics (BBL), the expected consolidation of the Biologics arm, and improving fundamentals

Stocks to Watch today: Adani Enterprises, ICICI Bank, Biocon, Ola Electric

Stocks to Watch today, December 8, 2025: Bajaj Finserv, ONGC, AU Small Finance Bank, P N Gadgil Jewellers, Cochin Shipyard, Delhivery, and TVS Motor Company are among the top stock to remain in focus

Even today, I think BBL at $5.5 billion is undervalued: Kiran Mazumdar-Shaw

'Can reinvest operating cash back into biz to scale up GLP-1s'

Biocon to integrate Biocon Biologics in $5.5-bn tranx, pivots away from IPO

Proposed transaction will result in Biocon Biologics becoming a wholly-owned subsidiary of Biocon, simplifying the group structure, and strengthening the consolidated balance sheet

Biocon to make Biocon Biologics a wholly owned subsidiary in $5.5 bn deal

Biocon Biologics Chief Executive Shreehas Tambe will become CEO and managing director of the combined entity post-integration

Biocon board to weigh BBL stake buyout, fundraising options on December 6

Biocon's board will meet on December 6 to consider acquiring Biocon Biologics shares from minority investors through cash or a share swap, and to approve fundraising options such as QIP, rights issue

Biocon stock tanks 6% on heavy volumes; what's triggered the sell-off?

The board of directors of Biocon are scheduled to meet on December 06, 2025, to consider and approve the proposals for investment in Biocon Biologics, an unlisted material subsidiary of the company.

Debt restructuring to reduce interest costs by ₹300 cr by FY27: Biocon CEO

CEO Shreehas Tambe says debt reduction, US state tie-ups, and five fresh product launches will strengthen Biocon Biologics' global biosimilar play

Stocks to Watch today: Bajaj Finserv, Biocon, BSE, Groww, TMCV, Tata Power

Stocks to Watch today: Groww, Tata Motors CV, Bajaj Finserv, Biocon, Bharat Forge, BSE and Tata Power are among the stocks to watch today, November 12, 2025

Biocon Q2FY26 results: Consolidated net profit at ₹84.5 cr, revenue up 21%

The biosimilars segment, operated by Biocon Biologics, reported revenues of Rs 2,721 crore, reflecting strong 25 per cent year-on-year growth

Q2 FY26 results today: Bajaj Finserv, Biocon, Godrej, and more on Nov 11

Q2FY26 company results: Firms including Bajaj Holdings & Investment, Bharat Forge, Bosch, Cera Sanitaryware and Hindustan Copper are also to release their July-September earnings reports today